We are live on
!
Find out more
ME
McIlrath & Eck Portfolio holdings
AUM
$1.35B
1-Year Est. Return
15.78%
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
–
AUM
$180M
AUM Growth
$0
(0%)
Cap. Flow
+$61.7K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
84.83%
Holding
643
New
–
Increased
3
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$59.8K |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$8.09K |
| 3 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
+$792 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$5.08K |
| 2 |
Aegon
AEG
|
+$1.03K |
| 3 |
VF Corp
VFC
|
+$689 |
| 4 |
HSBC
HSBC
|
+$126 |
| 5 |
Philips
PHG
|
+$64 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 1.81% |
| 3 | Consumer Discretionary | 1.65% |
| 4 | Industrials | 1.57% |
| 5 | Consumer Staples | 1.37% |
Similar funds
PGH
VHAM
HAM
WTB
MC
SEP
OCMI
TA
McIlrath & Eck's Q2 2019 Portfolio in Review
As of Q2 2019, McIlrath & Eck held 643 positions worth $180M, unchanged from the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Trading was light in Q2 2019: portfolio turnover was 0%. McIlrath & Eck opened no new positions and made no exits, leaving the 643-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, unchanged from a quarter earlier, followed by Financials and Consumer Discretionary.
- McIlrath & Eck added most to DuPont de Nemours in Q2 2019, an estimated $59.8K increase.
- McIlrath & Eck's biggest Q2 2019 reduction was Novartis, cutting an estimated $5.08K.
- McIlrath & Eck's ten largest holdings make up 85% of its $180M portfolio in Q2 2019.
- McIlrath & Eck opened 0 new positions and closed 0 in Q2 2019.
- McIlrath & Eck's portfolio value was unchanged quarter-over-quarter at $180M.
Based on McIlrath & Eck's 13F filing for Q2 2019, filed 8 Aug 2019.